Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
St. |
RCV000761136 | SCV000891052 | uncertain significance | Noonan syndrome | 2020-09-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000804507 | SCV000944419 | uncertain significance | RASopathy | 2023-09-10 | criteria provided, single submitter | clinical testing | This variant, c.547_552del, results in the deletion of 2 amino acid(s) of the KRAS protein (p.Thr183_Lys184del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (no rsID available, gnomAD 0.006%). This variant has been observed in individual(s) with cardio-facio-cutaneous syndrome (PMID: 22495831). ClinVar contains an entry for this variant (Variation ID: 620625). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. |
Fulgent Genetics, |
RCV005004406 | SCV002789244 | uncertain significance | Familial cancer of breast; Noonan syndrome 3; Linear nevus sebaceous syndrome; Toriello-Lacassie-Droste syndrome; Cerebral arteriovenous malformation; Malignant tumor of urinary bladder; Autoimmune lymphoproliferative syndrome type 4; Acute myeloid leukemia; Cardiofaciocutaneous syndrome 2; Familial pancreatic carcinoma; Gastric cancer; Lung cancer | 2024-04-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV004597873 | SCV005092462 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | KRAS: PM4, BS1 |